Pfizer's New Ceo Announces Shift in Leadership ; Veteran Who Vied for Top Job Is Out

Summary


In his first significant move as head of the world's largest drug maker, newly appointed CEO Jeffrey Kindler on Tuesday announced a shake-up at the highest ranks of the corporate ladder.

Vice Chairman Karen Katen, a 30-year Pfizer veteran and head of human health operations, is leaving "to pursue other opportunities," according to a statement released by the company.

See the full content of this document

Extract


Pfizer's New Ceo Announces Shift in Leadership ; Veteran Who Vied for Top Job Is Out

Katen was one of three candidates vying to replace former CEO Henry "Hank" McKinnell. Kindler and...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company